BCRX
BioCryst Pharmaceuticals (BCRX)
$20
About BioCryst Pharmaceuticals (BCRX)
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
Details
Daily high
$7.52
Daily low
$7.18
Price at open
$7.51
52 Week High
$8.88
52 Week Low
$4.03
Market cap
1.5B
Dividend yield
0.00%
Volume
1.6M
Avg. volume
1.7M
P/E ratio
-9.86
BioCryst Pharmaceuticals News
Details
Daily high
$7.52
Daily low
$7.18
Price at open
$7.51
52 Week High
$8.88
52 Week Low
$4.03
Market cap
1.5B
Dividend yield
0.00%
Volume
1.6M
Avg. volume
1.7M
P/E ratio
-9.86